SNOA stock forecast
Our latest prediction for Sonoma Pharmaceuticals, Inc.'s stock price was made on the March 13, 2018 when the stock price was at 4.02$.
In the short term (2weeks), SNOA's stock price should outperform the market by 2.86%. During that period the price should oscillate between -7.73% and +14.78%.
In the medium term (3months), SNOA's stock price should outperform the market by 3.21%. During that period the price should oscillate between -17.74% and +42.76%.Get email alerts
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
At the moment the company generates 18M USD in revenues.
On its last earning announcement, the company reported a loss of -2.67$ per share.
The book value per share is 1.96$
Three months stock forecastMarch 13, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|